For example, the colony-stimulating factor-1 receptor (CSF-1R) is an attractive combination immunotherapeutic agent for tumor treatment by targeting TAMs (Mok et al., 2014; Cannarile et al., 2017; Razak et al., 2020). This evidence concerns the gene CSF1R and neoplasm.